Insider filing · MDGL
Madrigal Pharmaceuticals, Inc.
MDGL · Healthcare · 60 filings in 24 months
ticker →
Baker Bros. Advisors Lp bought $35.0M of Madrigal Pharmaceuticals (MDGL)
Executed Nov 4, disclosed Nov 6, 2 days later.
Value, as filed
$35.0M
91,806 sh across 5 lots
Executed
Nov 4
the trade date, as filed
Disclosed
Nov 6
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
BL
Baker Bros. Advisors Lp
Other
profile →
Baker Bros. Advisors Lp (Other) filed 10 Form 4 reports as a reporting entity in the trailing twelve months (9 purchases, 1 sale), most often in Kodiak Sciences Inc. (KOD). Across 7 priced purchase filings, the average 21-session return was +27.3% from execution and +5.7% from disclosure (delay-adjusted; derived). The largest single filing was $317.8M of CELC (3,100,000 sh across 2 lots, as filed), executed Jul 14.
The name
MDGLHealthcare · Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Baker Bros. Advisors Lp in MDGL
MDGLPURCHASE
Madrigal Pharmaceuticals, Inc.
$36.7M96,519 sh across 22 lots
Exec Aug 18 2025
Filed Aug 20 2025 · 6:12 PM ET MDGLPURCHASE Madrigal Pharmaceuticals, Inc. $24.5M
67,279 sh across 21 lots
Exec Aug 18 2025
Filed Aug 20 2025 · 6:09 PM ET